Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-039086

CBO & COO sold 70,000 shares at an average $75.88 ($5,311,564)

  • CBO & COO acquired 70,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klein Lawrence Otto CBO & COO 2020-06-24 Option exercise +38,666 $5.86 $226,583 58,666 D
Klein Lawrence Otto CBO & COO 2020-06-24 Sale −15,966 $75.93 $1,212,265 42,700 D
Klein Lawrence Otto CBO & COO 2020-06-24 Sale −22,700 $76.50 $1,736,575 20,000 D
Klein Lawrence Otto CBO & COO 2020-06-24 Option exercise +26,422 $12.57 $332,125 46,422 D
Klein Lawrence Otto CBO & COO 2020-06-24 Sale −6,600 $74.90 $494,323 39,822 D
Klein Lawrence Otto CBO & COO 2020-06-24 Sale −3,934 $75.94 $298,736 35,888 D
Klein Lawrence Otto CBO & COO 2020-06-24 Sale −800 $76.50 $61,201 35,088 D
Klein Lawrence Otto CBO & COO 2020-06-24 Sale −12,175 $75.32 $917,054 22,913 D
Klein Lawrence Otto CBO & COO 2020-06-24 Sale −2,913 $76.26 $222,138 20,000 D
Klein Lawrence Otto CBO & COO 2020-06-25 Option exercise +4,912 $12.57 $61,744 24,912 D
Klein Lawrence Otto CBO & COO 2020-06-25 Sale −4,912 $75.18 $369,272 20,000 D
Derivatives
Klein Lawrence Otto CBO & COO 2020-06-24 Option exercise · Stock Option (Right to Buy) −38,666 0 D
Klein Lawrence Otto CBO & COO 2020-06-24 Option exercise · Stock Option (Right to Buy) −26,422 13,578 D
Klein Lawrence Otto CBO & COO 2020-06-25 Option exercise · Stock Option (Right to Buy) −4,912 8,666 D
Open-market sales · 70,000 sh · avg $75.88 · $5,311,564
Loading xslF345X03/doc4.xml…